BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 24372809)

  • 1. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N; Adil SN; Shaikh MU
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.
    Almyroudis NG; Fuller A; Jakubowski A; Sepkowitz K; Jaffe D; Small TN; Kiehn TE; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2005 Mar; 7(1):11-7. PubMed ID: 15984943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome.
    Mendes ET; Dulley F; Basso M; Batista MV; Coracin F; Guimarães T; Shikanai-Yasuda MA; Levin AS; Costa SF
    Int J Infect Dis; 2012 Jun; 16(6):e424-8. PubMed ID: 22463920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations.
    Youssef A; Hafez H; Madney Y; Elanany M; Hassanain O; Lehmann LE; El Haddad A
    Pediatr Transplant; 2020 Feb; 24(1):e13610. PubMed ID: 31682054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month incidence of bloodstream infections in intestinal transplant patients.
    Akhter K; Timpone J; Matsumoto C; Fishbein T; Kaufman S; Kumar P
    Transpl Infect Dis; 2012 Jun; 14(3):242-7. PubMed ID: 22093913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents.
    Devrim İ; Kara A; Düzgöl M; Karkıner A; Bayram N; Temir G; Şencan A; Sorguç Y; Gülfidan G; Hoşgör M
    Burns; 2017 Feb; 43(1):144-148. PubMed ID: 27615546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.
    Mikulska M; Del Bono V; Bruzzi P; Raiola AM; Gualandi F; Van Lint MT; Bacigalupo A; Viscoli C
    Infection; 2012 Jun; 40(3):271-8. PubMed ID: 22187340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion.
    Cappellano P; Viscoli C; Bruzzi P; Van Lint MT; Pereira CA; Bacigalupo A
    New Microbiol; 2007 Apr; 30(2):89-99. PubMed ID: 17619251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.
    Yan CH; Wang Y; Mo XD; Sun YQ; Wang FR; Fu HX; Chen Y; Han TT; Kong J; Cheng YF; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S162-S173. PubMed ID: 30423054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower.
    Rodríguez-Créixems M; Muñoz P; Martín-Rabadán P; Cercenado E; Guembe M; Bouza E
    Clin Microbiol Infect; 2013 Sep; 19(9):845-51. PubMed ID: 23565810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
    Hong J; Moon SM; Ahn HK; Sym SJ; Park YS; Park J; Cho YK; Cho EK; Shin DB; Lee JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):994-9. PubMed ID: 23571460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.